Contents:

DATAMONITOR HEALTHCARE ACTION POINTS Outline of the brief Three key things you need to know about operating within the eHealth Regulatory Environment in Europe Given the uncertainty of the final outcome of DTC pilots and their prospectively lengthy turnaround time, pharmaceutical companies should focus their attention on taking full advantage of their current opportunities Positioning a website as educational as opposed to promotional is a key factor in avoiding regulatory infringements Marketers must respect the intention behind the proposed DTC regulations rather than simply following the letter of the law or they risk a backlash with stricter regulations than currently exist eHEALTH REGULATORY ENVIRONMENT IN EUROPE Introduction Methodology Regulations involving online direct-to-consumer marketing Overview of the pharmaceutical marketing controls Self-regulatory organizations Regulatory legislation Promotion vs. education Regulations involving data protection Directive 95/46/EC Safe Harbor Privacy Principles THE FUTURE DECODED Outlook for eHealth regulatory environment European Commission proposal to relax portions of the ban on DTC advertising A general strategy for regulatory compliance Navigating through the changing regulatory landscape APPENDIX Datamonitor’s eHealthInsight Business Unit Table of figures References Addendum 1 to IFPMA Code of Pharmaceutical Marketing Practices EFPIA Code for Online Pharmaceutical Marketing WHO Criteria for Medicinal Drug Promotion Relevant links Research methodology SPP writing team How to contact experts in your industry